baber/WOPTO huggingface dataset:
Patent NZ-568839-A (NZ)
Title: Mixing of chemicals into a thin stock pipe
Inventor: JACOBSON TOMMY
IPC: B01F15/02
Filed: 2006-12-14
Abstract: Disclosed is a method of mixing one or more chemicals into a process stream in a thin stock pipe of a papermaking process comprising the steps of: a. running said papermaking process so that said process stream flows through said thin stock pipe; b. drawing a portion of said process stream from said thin stock pipe; c. adding said chemicals to said portion of said process stream so that a mixture forms; and d. feeding said mixture into said thin stock pipe so that said mixture mixes with said process stream.
Patent NZ-578038-A (NZ)
Title: Plating or coating method for producing metal-ceramic coating on a substrate
Inventor: GAO WEI
IPC: C23C20/00
Filed: 2010-06-29
Abstract: Disclosed is a method of producing a metal-ceramic composite coating on a substrate in an electroless plating or coating process or a galvanic plating process which includes preparing a plating solution or electrolyte and immersing the substrate to be coated in the plating solution or electrolyte, which includes adding a sol of a ceramic phase to the plating solution or electrolyte. Also disclosed is an item that has been plated or coated by the process.
Patent NZ-580381-A (NZ)
Title: Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
Inventor: FRANK ROBERT
IPC: A61K31/4545
Filed: 2008-04-15
Abstract: Disclosed are pyridine compounds of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are: 2-(3,4-Diaminophenyl)-N-((2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methyl)propanamide, N-(2-Butoxy-6-tert-butylpyridin-3-ylmethyl)-2-(3,4-diamino-phenyl)-propionamide and N-( (6-tert -Butyl-2-( 4-methylpiperid in-1-yl)pyridin-3-yl)methyl)-2-(3,4-diaminophenyl)propanamide. Also disclosed is a process for preparing compounds of formula (I), a pharmaceutical composition comprising a compound of formula (I) and the use of a compounds of formula (I) in the manufacture of a medicament for the treatment and/or prophylaxis of any one or more of the disorders selected from the group consisting of pain, including pain selected from the group consisting of acute pain, chronic pain, neuropathic pain, and visceral pain; arthralgia; hyperalgesia; allodynia; causalgia and migraine.
Patent NZ-584236-A (NZ)
Title: Wind turbine rotor with vertical rotation axis with rotors arranged for greater durability
Inventor: NAUMENKO ANATOLIY
IPC: F03D3/06
Filed: 2008-11-05
Abstract: Disclosed is a wind turbine rotor with a vertical rotation axis. The rotor has, connected with a hub (1), at least two horizontal supports (2) on the ends of which are rotor blades (3). The rotor blades are of a symmetrical and concavo-convex aerodynamic profile with the chord lengths (b1, b2) and the thickness of the profile diminishing towards both wing ends (3a, 3b). The upper wing (3a) and the lower wing (3b) of the rotor blades are radially deflected from the central zone (3c) outwards. The length of the chords of the profile of both wing ends and the chord length in the central zone are approximately inversely proportional to the radii of its location in relation to the axis of the rotor's rotation. The invention aims to provide a rotor which gives a uniform intensity of consuming wind power at the length of the wings and generally in the support only tensile stress is generated while the hazard of flutter is practically eliminated.
Patent NZ-587846-A (NZ)
Title: Clamp for clamping a blade for a wind turbine and method of installing wind turbine blades
Inventor: MAJ KARL AAGE
IPC: F03D11/00
Filed: 2010-09-07
Abstract: A method of installing the blades to the hub of a wind turbine includes: lifting the first blade, rotating it around a transverse axis of the blade and mounting the blade to the hub; lifting the second blade and rotating it around a transverse axis of the blade and mounting the second blade to the hub; rotating the hub 180° around a vertical axis, then: lifting the third blade, rotating the blade around a longitudinal axis of the blade and mounting the third blade to the hub. A specially adapted crane and blade gripping and manipulating mechanism to facilitate performance of the method is disclosed and claimed.
Patent NZ-594000-A (NZ)
Title: Pipe part provided with a spigot end part
Inventor: BRISTOW ADRIAN DAVID
IPC: F16L21/03
Filed: 2010-01-12
Abstract: A pipe part 1 provided with a spigot end part 2 for insertion into a socket end part having on the inside a sealing ring, the spigot end part 2 having an outer end structure which comprises in circumferential direction in alternating fashion radially inwardly situated sections 4, and relative to these inwardly situated sections 4, radially outwardly directed protuberances 5. At least one of the protuberances 5 has a protuberance-shape with a portion that does not coincide with a number of imaginary cones whose axis is collinear with the pipe axis. The protuberances have a base crossing the pipe part and coincide the imaginary cone at least one point.
Patent NZ-595357-A (NZ)
Title: A device to detect the presence or absence of events in a sample using prime numbers
Inventor: VAN DEN BULCKE MARC HENRI GERMAIN
IPC: C12Q1/00
Filed: 2008-01-29
Abstract: A computing device programmed to carry out steps to conclude the presence or absence of one or more events in a sample, wherein each event is characterised by one or more traits, and wherein the presence or absence of the one or more traits in the sample has been detected is disclosed. The steps comprise: (a) assigning a unique prime number value to each trait, (b) representing each event as a product of the prime number values assigned to traits characteristic of the event, (c) representing the sample as a product of the prime number values assigned to traits detected as present in the sample, and (d) dividing the product representing the sample as defined in (c) by the product representing an event as defined in (b), whereby: - if the value obtained by the division equals 1, then the event or material thereof is potentially present in the sample; - if the value obtained by the division is an integer greater than 1, then the event or material thereof is potentially present in the sample; - if the value obtained by the division is not an integer, then the event or material thereof is absent from the sample.
Patent NZ-596691-A (NZ)
Title: Bracing design, assessment and applications thereafter
Inventor: GERLICH JOHAN THEODOOR
IPC: E04B2/00
Filed: 2011-11-25
Abstract: A method implemented on a computing device of assessing or designing the bracing resistance of/for a structure and a computing device to assist in assessing or designing the bracing resistance of/for a structure are disclosed. The structure can be a building or part thereof. The computing device is configured to a) for each wall along one or more bracing lines of the structure, receive a sum of horizontal lengths of full height wall sections between openings; b) receive selected sheet material bracing type(s) for each wall, c) receive a fastening pattern for fastening sheet material bracing of the selected type(s) to each wall and d) calculate, using the sum of horizontal lengths for each wall, the bracing resistance of each wall and/or the structure provided by the sheet material bracing type(s) when fastened to the wall(s) according to the fastening pattern. Also disclosed is a method of assessing or designing the bracing resistance of/for a structure comprising the steps of a) for each wall along one or more bracing lines of the structure, determining a sum of horizontal lengths of all full height wall sections between openings, b) specifying a sheet material bracing type(s) for each wall in the computing device, c) specifying a fastening pattern for fastening sheet material bracing of the selected type(s) to each wall in the computing device, d) determining, using the sum of horizontal lengths for each wall, the bracing resistance of each wall and/or the structure provided by the sheet material bracing type(s) when fastened to the wall(s) according to the fastening pattern using the above described computing device or the method implemented on a computing device of assessing or designing the bracing resistance of/for a structure, e) comparing the bracing resistance against a bracing demand, and f) where necessary, re-specifying in the computing device one or more alternative sheet material bracing types and/or modifying the fastening pattern(s) to adjust the bracing resistance to reassess the alternatives against bracing demand.
Patent NZ-597455-A (NZ)
Title: Wind power electricity generating system with an angular speed sensor fixed to the rotor
Inventor: VIHRIALA HARRI
IPC: F03D11/00
Filed: 2010-06-10
Abstract: A wind power electricity generating system 1 comprises a nacelle 3, a rotary assembly 16 rotating about an axis A2 with respect to the nacelle 3, an electric machine comprising a stator 12, a rotor 13 and an angular speed detection device 23 for detecting the angular speed of the rotary assembly 16. The angular speed detection device, 23 comprises at least one sensor 24 rotating about the axis A2 together with the rotary assembly 16, and supplies at least one signal related to angular speed. The rotary assembly 16 comprises a hub 4, at least one blade 5 fitted to the hub 4, and the rotor 13 of the electric machine 6, connected to the hub 4. The sensor 24 is fixed to the rotor 13 of the electric machine.
Patent NZ-602062-A (NZ)
Title: Cable sealing and retaining device and cable connection
Inventor: KEMPENEERS DIRK
IPC: H02G15/10
Filed: 2011-01-18
Abstract: The present invention relates to a cable sealing and retaining device providing at least two openings through each of which a cable is sealingly guidable, and to a cable termination formed between said two cables. The present invention provides an improved cable sealing and retaining device which is simply shaped, which may sealingly accommodate a connection formable between two cables received by the cable sealing and retaining device and which is capable of keeping away from the connection a tension force acting on the cable in its longitudinal direction. The cable sealing and retaining device (50) comprises at least two cable sealing devices (10) with sealing parts (11), each providing a passageway with an inner seal (14) through which a cable (2) is sealingly guidable, and an outer seal (15) arranged on an outer circumference of the sealing part (11). The cable sealing and retaining device (50) comprises a housing (53) which provides at least two openings (51) with a sealing section (52) arranged inside of the housing (53) and adapted to co-operate with a front section of the sealing part (11) received by the opening (51) to form a sealing between the sealing section (52) and the outer seal (15) coming into contact with the sealing section (52). The cable sealing and retaining device (50) is characterized by a tension support part (56) for bypassing a tension acting in longitudinal direction on the cable (2), wherein the tension support part (56) is provided between the cable sealing devices (10) and having a longitudinal length adapted to bridge a longitudinal distance between the two cable sealing devices (10).
Patent NZ-602101-A (NZ)
Title: Medicament dispenser device
Inventor: BROMLEY-DAVENPORT DARREN
IPC: A61M15/00
Filed: 2011-02-23
Abstract: 602101 A dispenser device (50) for dispensing a medicament, the device including at least one metallic component having at least one non-metallic surface which comes into contact with the medicament during storage or use of the device. The non-metallic surface has an interface with the underlying metallic component which substantially comprises metal-fluoride and/or metal carbide moieties. The interface comprises less than about 15 At% oxygen as measured by XPS.
Patent NZ-603167-A (NZ)
Title: Haemostatic material
Inventor: HARDY CRAIG
IPC: A61L15/28
Filed: 2009-04-27
Abstract: Disclosed is a haemostatic material comprising a carrier layer, an adhesive layer and a chitosan salt (such as chitosan acetate, chitosan lactate, chitosan succinate, chitosan malate, or chitosan acrylate) in particulate, granular, powder, flake or short fibrous form, wherein the haemostat or the adhesive layer is sufficiently water sensitive to weaken the bond between them upon contact with a fluid, such that when the adhesive layer is wet with blood, a portion of the haemostat will remain at the wound site if the carrier layer is removed.
Patent NZ-605850-A (NZ)
Title: Compounds with antibacterial activity against clostridium
Inventor: GUILLEMONT JERÔME EMILE GEORGES
IPC: C07D487/04
Filed: 2011-08-04
Abstract: The disclosure relates to family of chemical compounds, or their therapeutic salts thereof, than contain and chroman moiety (with an (R)-configuration at the 4-position) and a pyrazolo triazine moiety that linked by an amine containing alkyl chain. The family differ from each other by various substituents, including halogens, hydroxyl groups and alkly chains, attached to the ring structures. The disclosure also relates to the process of their formation, their intermediates, their use as a medicine for the use in the treatment of a bacterial, Clostridium based, infection.
Patent NZ-607282-A (NZ)
Title: Method for using gene expression to determine prognosis of prostate cancer
Inventor: SHAK STEVEN
IPC: G01N33/574
Filed: 2011-07-25
Abstract: Discloses a method for determining a likelihood of cancer recurrence in a human patient with prostate cancer, comprising: Measuring the expression level of GSTM2 in a biological sample; Predicting a likelihood of cancer recurrence for the patient based on the measure expression level of GSTM2; Wherein an increased expression level of GSTM2 is negatively associated with an increased risk of recurrence.
Patent NZ-609949-A (NZ)
Title: Method and apparatus for detecting cardiac signals
Inventor: FARRUGIA STEVEN PAUL
IPC: A61B5/0205
Filed: 2011-11-14
Abstract: A device provides methods for detecting cardiac signals from facial biopotential sensors (110) is disclosed. The device comprises a set of facial electrodes; a processor (116), coupled with the set of facial electrodes. The processor (116) configured to control a detection of a cardiac signal from a facial biopotential signal (114) measured with the set of facial electrodes. Moreover, one or more facial biopotential electrodes for measuring the facial biopotential signal (114) may be integrated in or at a contact surface of head support structures such as a headgear support or respiratory treatment mask. Moreover, a controller of a respiratory treatment apparatus may serve as a cardiac signal detector by processing the facial biopotential signal (114) from the sensors (110) and may make control adjustments or generate warnings based on an evaluation of detected signals.
Patent NZ-610931-A (NZ)
Title: Envelopes and methods for their production
Inventor: MACGREGOR CHRISTIAN
IPC: B31B50/64
Filed: 2011-10-27
Abstract: 610931 An envelope is formed from continuous COPP film web by pre-creasing envelope body and flap fold lines (13, 14) along the web, continuously installing an adhesive tape along the flap portions and pre-cutting relief slots in the web corresponding to the flap side edges (15). The pre-creased web is folded and cut into individual envelopes by hot knife cutting, whereby the presence of the slots prevents the flaps (12) from welding to the side seams even with the flap folded over. Envelopes produced by the method are suited to automatic stuffing. Apparatus for making envelopes in accordance with the invention is also described.
Patent NZ-617629-A (NZ)
Title: Treatment of mastitis
Inventor: SA DE CARLOS
IPC: A61P31/04
Filed: 2012-05-11
Abstract: Provided are veterinary compositions comprising a toll like receptor (TLR) agonist and an antibacterial agent for the treatment of mastitis in ruminants. A preferred TLR agonist is Kdo2-lipid A (re-LPS), a lipopolysaccharide. Preferred antibacterial agents include penicillin, neomycin and cefquinome.
Patent NZ-620033-A (NZ)
Title: Method and apparatus for surface treatment of materials utilizing multiple combined energy sources
Inventor: MISTRY PRAVIN
IPC: D06M10/02
Filed: 2012-06-28
Abstract: Material treatment is effected in a treatment region (124) by at least two energy sources, such as (i) an atmospheric pressure (AP) plasma and (ii) an ultraviolet (UV) laser directed into the plasma and optionally onto the material being treated. Precursor materials may be dispensed before, and finishing material may be dispensed after treatment. Electrodes (el, e2) for generating the plasma may comprise two spaced-apart rollers (212/214). Nip rollers adjacent the electrode rollers define a semi-airtight cavity, and may have a metallic outer layer.
Patent NZ-622875-A (NZ)
Title: Conduit space recovery system
Inventor: ALLEN JERRY L
IPC: H02G3/04
Filed: 2012-11-19
Abstract: An apparatus for cutting a duct (11) which surrounds a cable (12) in a longitudinally extending conduit (10) is disclosed. The apparatus comprises a drive assembly (23) adapted to engage and pull the duct out of the conduit, and a cutting assembly (25) positioned to longitudinally cut the duct as it is being pulled by the drive assembly. Methods of recovering space in a conduit, by removing a cable duct, are also disclosed.
Patent NZ-701896-A (NZ)
Title: Strains of propionibacterium
Inventor: MORGENSTERN HEIKE URSULA
IPC: C12N1/38
Filed: 2013-05-21
Abstract: The present invention relates to novel strains of Propionibacterium as well as preparations and compositions, such as fermentation broths, protective cultures, final food or feed product with Propionibacterium alone or in combination with bacteria of the genus Lactobacillus. The present invention further relates to methods for the controlling of growth of a contaminant, such as a bacteria, yeast or mould by using these novel strains of Propionibacterium.
Patent NZ-702931-A (NZ)
Title: Blister pack
Inventor: JOLLEY NICHOLAS
IPC: B65D75/36
Filed: 2013-06-24
Abstract: A blister pack for containing medicament in powder form for use within an inhalation device, the blister pack comprising an elongate strip of base material containing equally spaced recesses along the length of the strip, each recess having walls defining a cavity, and a lid hermetically sealed onto the base material to close the cavities and define pockets of medicament powder, the blister strip being adapted to have each recess filled with a metered dose of medicament powder, each recess being elongate having its longitudinal axis extending across the strip and having longer side walls joined by a base, whereby the volume of each recess is adapted to be greater than the volume of the metered dose and each pocket of the blister strip is adapted to be opened by either pulling back the lid or puncturing the lid or the walls of the recess.
Patent NZ-705492-A (NZ)
Title: Use of pedf-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
Inventor: TSAO YEOU-PING
IPC: C12N5/074
Filed: 2012-08-09
Abstract: Provided is a synthetic peptide derived from PEDF, which has 20-39 amino acid residues. Also provided are pharmaceutical compositions containing the synthetic peptide and the use thereof. The peptide is useful in promoting muscle or tendon regeneration, and/or arteriogenesis in a subject.
Patent NZ-706876-A (NZ)
Title: A nucleotide sequence and a process thereof
Inventor: GOVINDAPPA NAGARAJ
IPC: C12N15/81
Filed: 2012-12-05
Abstract: The present disclosure relates to a process of identification and isolation of sorbitol dehydrogenase promoter from Pichia pastoris. Further, the present disclosure also relates to expression of heterologous proteins under the control of Sorbitol dehydrogenase promoter in Pichia pastoris.
Patent NZ-710384-A (NZ)
Title: A novel formulation of indomethacin
Inventor: MEISER FELIX
IPC: A61K31/405
Filed: 2010-04-23
Abstract: Disclosed are methods for producing particles of a biologically active material using dry milling processes as well as compositions comprising such materials, medicaments produced using said biologically active materials in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of said biologically active materials administered by way of said medicaments. wherein when tested using USP Apparatus I (baskets) set to rotation speed of 100 RPM in 900 mL of 100mM citric acid buffer at pH 5.5±0.05 at 37±0.5°C, the milled indomethacin has a dissolution profile of no less than 50% dissolution, by weight, at 60 minutes, when measured under sink conditions.
Patent NZ-713114-A (NZ)
Title: 2-aminopyrido[4,3-d]pyrimidin-5-one derivatives and their use as wee-1 inhibitors
Inventor: O’DOWD COLIN RODERICK
IPC: A61P35/00
Filed: 2014-04-11
Abstract: The present invention relates to compounds of formula (I) that are useful as inhibitors of the activity of Wee-1 kinase. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer.
Patent NZ-720736-A (NZ)
Title: Antibody drug conjugates (adcs) with kinesin spindel protein (ksp)
Inventor: GRIEBENOW NILS
IPC: C07D233/64
Filed: 2014-12-10
Abstract: The invention relates to novel antibody drug conjugates (ADCs) of formula (IIa), active metabolites of said ADCs, to methods for producing said ADCs, to the use of said ADCs for the treatment and/or prevention of diseases, and to the use of said ADCs for the production of medicaments for the treatment and/or prevention of diseases, in particular hyperproliferative and angiogenic diseases, such as cancer diseases. Such treatments can be effected as monotherapy or else in combination with other medicaments or further therapeutic measures.
Patent NZ-720765-A (NZ)
Title: Antibodies and methods of use
Inventor: CHEN YONGMEI
IPC: C07K14/71
Filed: 2014-12-23
Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB. In a particular embodiment, the bispecific antibody or antigen binding portion thereof binds to FGFR1c and a KLB epitope within a fragment of KLB consisting of the amino acid sequence SSPTRLAVIPWGVRKLLRWVRRNYGDMDIYITAS (SEQ ID NO: 142). In a further embodiment, the bispecific antibody comprises a first arm having the heavy chain CDRs: TYGVH, VIWSGGSTDYNAAFIS and DYGSTYVDAIDY; and the light chain CDRs RASESVESYGNRYMT, RAANLQS, and QQSNEDPWT; and a second arm comprising the heavy chain CDRs: SNYIS, EIDPYDGDTYYADSVKG and GTDVMDY; and the light chain CDRs RASQDVSTAVA, SASFLYS, and QQSYTTPPT.
Patent NZ-732044-A (NZ)
Title: Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
Inventor: KANDULA MAHESH
IPC: C07D295/02
Filed: 2014-12-29
Abstract: The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of salts of formula I or formula II; and methods for treating or preventing multiple sclerosis may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of neurodegenerative diseases and psoriasis.